| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa45e723acac586815d7c2524dea6bdd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5082 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate |
2016-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5309c3fc1364c6478ddba3b279a2f12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7834163a87889f213562c6b01e13299a |
| publicationDate |
2021-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3818826-A1 |
| titleOfInvention |
Isolated organ evaluation and treatment |
| abstract |
The present invention relates to methods of treating organs during isolated organ perfusion comprising perfusing the isolated organ with a perfusate which comprises a tissue factor (TF) suppressor molecule. |
| priorityDate |
2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |